-
A year after the Food and Drug Administration (FDA) approved behind-the-counter status for the emergency contraceptive (EC) pill Plan B (Barr Pharmaceuticals; Pomona, NY) is the drug more available to women? While the company says sales have increased from about $40 million annually to an expected $80 million for 2007, availability is mixed, according to reports around the country.
-
Understanding sexual behavior is an important piece of the family planning puzzle, and a new national report provides insights on current sexual practices.1
-
Results of a new survey indicate that in women experiencing heavy periods, pain is the most commonly reported problem.1 What are some clinical strategies to help ease these symptoms?
-
Results from a new international meta-analysis study of Gardasil (Merck & Co.; Whitehouse Station, NJ), the cervical cancer vaccine, indicate the shot is nearly 100% effective against the two types of the human papillomavirus (HPV) responsible for most cases of cervical cancer.
-
The ECG in the Figure was obtained from a 59-year old man with hypertension. He was admitted to the hospital to rule out acute infarction because of an "unpleasant sensation" in his chest.
-
SSRIs are associated with a low rate of birth defects according to 2 new studies in the New England Journal of Medicine. SSRIs are often taken by women in their childbearing years, but the risk of birth defects has been unclear.
-
-
In this retrospective study of C. difficile colitis due to a hypervirulent strain, 53% of 165 patients died.
-
-
Estrogen for Younger Postmenopausal Women; Warfarin Better for Atrial Fibrillation Patients; FDA Actions